Locus-specific Databases and Recommendations to Strengthen Their Contribution to the Classification of Variants in Cancer Susceptibility Genes

Overview

Journal Hum Mutat

Specialty Genetics

Date 2008 Oct 28

PMID 18951438

Citations 18

Authors

Marc S Greenblatt

Lawrence C Brody

William D Foulkes

Maurizio Genuardi

Robert M W Hofstra

Magali Olivier

Sharon E Plon

Rolf H Sijmons

Olga Sinilnikova

Amanda B Spurdle

Affiliations

Soon will be listed here.

Abstract

Locus-specific databases (LSDBs) are curated collections of sequence variants in genes associated with disease. LSDBs of cancer-related genes often serve as a critical resource to researchers, diagnostic laboratories, clinicians, and others in the cancer genetics community. LSDBs are poised to play an important role in disseminating clinical classification of variants. The IARC Working Group on Unclassified Genetic Variants has proposed a new system of five classes of variants in cancer susceptibility genes. However, standards are lacking for reporting and analyzing the multiple data types that assist in classifying variants. By adhering to standards of transparency and consistency in the curation and annotation of data, LSDBs can be critical for organizing our understanding of how genetic variation relates to disease. In this article we discuss how LSDBs can accomplish these goals, using existing databases for BRCA1, BRCA2, MSH2, MLH1, TP53, and CDKN2A to illustrate the progress and remaining challenges in this field. We recommend that: 1) LSDBs should only report a conclusion related to pathogenicity if a consensus has been reached by an expert panel. 2) The system used to classify variants should be standardized. The Working Group encourages use of the five class system described in this issue by Plon and colleagues. 3) Evidence that supports a conclusion should be reported in the database, including sources and criteria used for assignment. 4) Variants should only be classified as pathogenic if more than one type of evidence has been considered. 5) All instances of all variants should be recorded.

Citing Articles

NGS-Panel Diagnosis Developed for the Differential Diagnosis of Idiopathic Toe Walking and Its Application for the Investigation of Possible Genetic Causes for the Gait Anomaly.

Pomarino D, Emelina A, Heidrich J, Rostasy K, Schirmer S, Schonfeldt J Glob Med Genet. 2023; 10(2):63-71.

PMID: 37091313 PMC: 10121371. DOI: 10.1055/s-0043-57230.

Computational approaches for predicting variant impact: An overview from resources, principles to applications.

Liu Y, Yeung W, Chiu P, Cao D Front Genet. 2022; 13:981005.

PMID: 36246661 PMC: 9559863. DOI: 10.3389/fgene.2022.981005.

A Population-Based Analysis of / Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study.

Park K, Lee W, Seong M, Kong S, Lee K, Ha J Cancers (Basel). 2021; 13(9).

PMID: 34063308 PMC: 8125125. DOI: 10.3390/cancers13092192.

Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network.

Garrett A, Callaway A, Durkie M, Cubuk C, Alikian M, Burghel G J Med Genet. 2020; 57(12):829-834.

PMID: 32170000 PMC: 7691806. DOI: 10.1136/jmedgenet-2019-106759.

Lessons learned from two decades of BRCA1 and BRCA2 genetic testing: the evolution of data sharing and variant classification.

Toland A, Brody L Genet Med. 2018; 21(7):1476-1480.

PMID: 30474649 PMC: 9936330. DOI: 10.1038/s41436-018-0370-4.

References

Cotton R, Auerbach A, Brown A, Carrera P, Christodoulou J, Claustres M . A structured simple form for ordering genetic tests is needed to ensure coupling of clinical detail (phenotype) with DNA variants (genotype) to ensure utility in publication and databases. Hum Mutat. 2007; 28(10):931-2. DOI: 10.1002/humu.20631. View

Couch F, Weber B . Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Hum Mutat. 1996; 8(1):8-18. DOI: 10.1002/humu.1380080102. View

Hofstra R, Spurdle A, Eccles D, Foulkes W, de Wind N, Hoogerbrugge N . Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance. Hum Mutat. 2008; 29(11):1292-303. PMC: 2966299. DOI: 10.1002/humu.20894. View

Hollstein M, Rice K, Greenblatt M, Soussi T, Fuchs R, Sorlie T . Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 1994; 22(17):3551-5. PMC: 308317. View

Auclair J, Leroux D, Desseigne F, Lasset C, Saurin J, Joly M . Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation. Hum Mutat. 2007; 28(11):1084-90. DOI: 10.1002/humu.20569. View

Antonarakis S . Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat. 1998; 11(1):1-3. DOI: 10.1002/(SICI)1098-1004(1998)11:1<1::AID-HUMU1>3.0.CO;2-O. View

Tavtigian S, Deffenbaugh A, Yin L, Judkins T, Scholl T, Samollow P . Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet. 2005; 43(4):295-305. PMC: 2563222. DOI: 10.1136/jmg.2005.033878. View

Chao E, Velasquez J, Witherspoon M, Rozek L, Peel D, Ng P . Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat. 2008; 29(6):852-60. DOI: 10.1002/humu.20735. View

Lehman C, Holt S, Peacock S, White E, Urban N . Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms. AJR Am J Roentgenol. 2002; 179(1):15-20. DOI: 10.2214/ajr.179.1.1790015. View

10.

Soussi T, Ishioka C, Claustres M, Beroud C . Locus-specific mutation databases: pitfalls and good practice based on the p53 experience. Nat Rev Cancer. 2006; 6(1):83-90. DOI: 10.1038/nrc1783. View

11.

Spurdle A, Lakhani S, Healey S, Parry S, da Silva L, Brinkworth R . Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators. J Clin Oncol. 2008; 26(10):1657-63. DOI: 10.1200/JCO.2007.13.2779. View

12.

Ou J, Niessen R, Lutzen A, Sijmons R, Kleibeuker J, de Wind N . Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes. Hum Mutat. 2007; 28(11):1047-54. DOI: 10.1002/humu.20580. View

13.

Williams R, Chasman D, Hau D, Hui B, Lau A, Glover J . Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations. J Biol Chem. 2003; 278(52):53007-16. DOI: 10.1074/jbc.M310182200. View

14.

Gout A, Ravine D, Harris P, Rossetti S, Peters D, Breuning M . Analysis of published PKD1 gene sequence variants. Nat Genet. 2007; 39(4):427-8. DOI: 10.1038/ng0407-427. View

15.

Plon S, Eccles D, Easton D, Foulkes W, Genuardi M, Greenblatt M . Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat. 2008; 29(11):1282-91. PMC: 3075918. DOI: 10.1002/humu.20880. View

16.

Monteiro A, Couch F . Cancer risk assessment at the atomic level. Cancer Res. 2006; 66(4):1897-9. DOI: 10.1158/0008-5472.CAN-05-3034. View

17.

Tavtigian S, Greenblatt M, Lesueur F, Byrnes G . In silico analysis of missense substitutions using sequence-alignment based methods. Hum Mutat. 2008; 29(11):1327-36. PMC: 3431198. DOI: 10.1002/humu.20892. View

18.

Eberl M, Fox C, Edge S, Carter C, Mahoney M . BI-RADS classification for management of abnormal mammograms. J Am Board Fam Med. 2006; 19(2):161-4. DOI: 10.3122/jabfm.19.2.161. View

19.

Easton D, Deffenbaugh A, Pruss D, Frye C, Wenstrup R, Allen-Brady K . A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet. 2007; 81(5):873-83. PMC: 2265654. DOI: 10.1086/521032. View

20.

Cotton R, Phillips K, Horaitis O . A survey of locus-specific database curation. Human Genome Variation Society. J Med Genet. 2007; 44(4):e72. PMC: 2598041. DOI: 10.1136/jmg.2006.044081. View